back-office Open An Account
partner-with-us Partner with Us
Corporate Actions
Stock Alert: Alembic Pharma, Bajel Projects, Zydus Lifesciences, Lupin, Adani Enterprises, Biocon

30-Sep-24   08:34 Hrs IST
Stocks to watch:

Alembic Pharmaceuticals' oral solid formulation facility (F-1) located in Panelav, Gujarat received establishment inspection report (EIR) from United States Food and Drug Administration (USFDA), which was inspected by USFDA from 17 July to 26 July 2024.

Bajel Projects had successfully entered the emerging data centre segment by securing its first order from an upcoming data centre service provider. The order involves the design and construction of a 220/33kV gas-insulated switchgear (GIS) substation and transmission line extension for a colocation data centre in Navi Mumbai, Maharashtra.

Zydus Lifesciences received final approval from the United States Food and Drug Administration (USFDA) to manufacture Enzalutamide Capsules, 40 mg.

Lupin's Pithampur facility in Madhya Pradesh, which includes the unit-1 API and finished product manufacturing site, has completed the U.S. Food and Drug Administration (USFDA) inspection with 3 observations.

Adani Enterprises' unit April Moon will acquire a 74% stake in Cococart Ventures for Rs 200 crore.

Adani Energy Solutions has signed a business transfer agreement with its subsidiary, North Maharashtra Power to carve out the Adani Dahanu Thermal Power Station. Adani Electricity Mumbai is a subsidiary of the company.

IndusInd Bank's board has approved the re-apppointment of Sumant Kathpali as managing director & chief executive officer (CEO) for a term of three years, effective from 24 March 2025.This re-appointment is subject to approval by the reserve bank of India and bank's shareholder.

Biocon's API facility (Site 2) in Bengaluru was inspected by US Food and Drug Administration (USFDA), from 23 September to 27 September 2024 ended with four observations.

Powered by Capital Market - Live News

Attention Investors: Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.|| KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.|| No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.